journal article·2024-04-16Open access

Binary Mixtures of Meloxicam and L-Tartaric Acid for Oral Bioavailability Modulation of Pharmaceutical Dosage Forms

Cristina Macasoi, Viorica Meltzer, Ioana Stanculescu, Cosmin Romanitan, Elena Pincu

Abstract

Binary mixtures of active pharmaceutical ingredients (API) are researched to improve the oral bioavailability of pharmaceutical dosage forms. The purpose of this study was to obtain mixtures of meloxicam and L-tartaric acid because tartaric acid improves intestinal absorption and meloxicam is more soluble in a weakly basic environment. The mixtures in the 0–1 molar fraction range, obtained from solvent-assisted mechanosynthesis, were investigated by differential scanning calorimetry (DSC), Fourier Transform Infrared (FTIR) spectroscopy, Fourier Transform Raman spectroscopy (FT-Raman), X-ray powder diffraction (XRD) and solubility tests. The physicochemical characteristics of the compounds obtained from DSC data reveal, for the first time, the formation of a co-crystal at meloxicam molar fraction of 0.5. FTIR spectroscopy data show the existence of hydrogen bonds between the co-crystal components meloxicam and L-tartaric acid. FT-Raman spectroscopy was used complementary with FT-IR spectroscopy to analyze the pure APIs and their mixtures, to emphasize the appearance/disappearance and the shifts of the position/intensity of vibrational bands, following the formation of hydrogen-bonded structures or van der Waals interactions, and to especially monitor the crystal lattice vibrations below 400 cm−1. The experimental results obtained by X-ray powder diffraction confirmed the formation of the co-crystal by the loss and, respectively, the apparition of peaks from the single components in the co-crystal diffractogram. The solubility tests showed that the co-crystal product has a lower aqueous solubility due to the acidic character of the other component, tartaric acid. However, when the solubility tests were performed in buffer solution of pH 7.4, the solubility of meloxicam from the co-crystal mixture was increased by 57% compared to that of pure meloxicam. In conclusion, the studied API mixtures may be considered potential biomaterials for improved drug release molecular solids.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · Analytical Chemistry and Chromatography

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Analytical Chemistry and Physical Chemistry, Faculty of Chemistry, University of Bucharest, 4-12 Regina Elisabeta Bd., 030018 Bucharest, Romania

Horia Hulubei National Institute for Physics and Nuclear Engineering, IRASM Department, 30 Reactorului Str., 077125 Magurele, Romania

National Institute for Research and Development in Microtechnologies (IMT Bucharest), 126A Erou Iancu Nicolae Street, 72996 Bucharest, Romania

Funding

Romanian Ministry of Research and Innovation

References (37)

Show source-provided references
1. Tablet formulation and enhancement of aqueous solubility of efavirenz by solvent evaporation co-crystal technique
2. Nanosizing of drugs: Effect of dissolution rate
3. Preparation and characterization of quercetin-loaded zein nanoparticles by electrospraying and study of in vitro bioavailability10.1111/1750-3841.14803 ↗
4. Role of Structure, Microenvironmental pH, and Speciation To Understand the Formation and Properties of Febuxostat Eutectics10.1021/acs.molpharmaceut.9b00716 ↗
5. Nugrahani, I., and Parwati, R.D. (2021). Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development. Molecules, 26.10.3390/molecules26144185 ↗
6. Preparation of meloxicam-salicylic acid co-crystal and its application in the treatment of rheumatoid arthritis10.1016/j.jddst.2022.103542 ↗
7. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam10.1016/j.jconrel.2021.12.038 ↗
8. Effect of inclusion complexation of meloxicam with β-cyclodextrin and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies10.1016/j.colsurfb.2015.09.002 ↗
9. Intermolecular interaction as a direct measure of water solubility advantage of meloxicam cocrystalized with carboxylic acids10.1007/s00894-018-3649-0 ↗
10. Structure and physicochemical properties of meloxicam, a new NSAID10.1016/0928-0987(95)00046-1 ↗
11. Supramolecular Architectures of Meloxicam Carboxylic Acid Cocrystals, a Crystal Engineering Case Study10.1021/cg100514g ↗
12. Effect of tartaric acid complexing agent on the extraction and separation of Pr and Nd by HDEHP in hydrochloric acid medium10.1016/j.mineng.2022.107538 ↗
13. Comparative study on tartaric acid production by two-chamber and three-chamber electro-electrodialysis10.1016/j.seppur.2021.118403 ↗
14. Coformer Selection in Pharmaceutical Cocrystal Development: A Case Study of a Meloxicam Aspirin Cocrystal That Exhibits Enhanced Solubility and Pharmacokinetics10.1002/jps.22434 ↗
15. Insights into mechanochemical reactions at the molecular level: Simulated indentations of aspirin and meloxicam crystals10.1039/C8SC04971H ↗
16. Cocrystallization as a novel approach to enhance the transdermal administration of meloxicam10.1016/j.ejps.2018.07.038 ↗
17. Synthesis of co-crystals of meloxicam with carboxylic acids by grinding10.1016/j.mencom.2009.09.014 ↗
18. Characterization of meloxicam and malonic acid cocrystal prepared with slurry method10.18860/jip.v3i2.6140 ↗
19. Cryosynthesis of Co-Crystals of Poorly Water-Soluble Pharmaceutical Compounds and Their Solid Dispersions with Polymers. The “Meloxicam−Succinic Acid” System as a Case Study10.1021/acs.cgd.8b01070 ↗
20. Synthesis and crystal structure of a meloxicam co-crystal with benzoic acid10.1007/s11224-018-1166-5 ↗
21. Are meloxicam dimers really the structure-forming units in the ‘meloxicam–carboxylic acid’ co-crystals family? Relation between crystal structures and dissolution behaviour10.1039/C1CE05902E ↗
22. Improving Solubility and Pharmacokinetics of Meloxicam via Multiple-Component Crystal Formation10.1021/mp300169c ↗
23. Crystal structure of a 2:1 co-crystal of meloxicam with acetylendicarboxylic acid
24. Biscaia, I.F.B., Gomes, S.N., Bernardi, L.S., and Oliveira, P.R. (2021). Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications. Pharmaceutics, 13.10.3390/pharmaceutics13060898 ↗
25. Popa, L., Ghica, M., and Moisescu, S. (2013). Biodisponibilitatea Medicamentului, Printech.
26. Detection of Cocrystal Formation Based on Binary Phase Diagrams Using Thermal Analysis10.1007/s11095-012-0850-1 ↗
27. Physico-chemical study of nitrazepam and citric acid eutectic mixture10.1016/j.tca.2023.179499 ↗
28. Yegireddy, M., Nadoor, P., Rao, S., Hanumanthu, P.B., Rajashekaraiah, R., Ramachandrappa, S.C., Halemani, G.M., Mannem, S., Prasad, T.N.V.K.V., and Ubaradka, S. (2022). Chitosan Encapsulated Meloxicam Nanoparticles for Sustained Drug Delivery Applications: Preparation, Characterization, and Pharmacokinetics in Wistar Rats. Molecules, 27.10.3390/molecules27217312 ↗
29. Mechanochemical synthesis, characterization, and thermal behavior of meloxicam cocrystals with salicylic acid, fumaric acid, and malic acid10.1007/s10973-019-08118-7 ↗
30. Synthesis and characterization of meloxicam eutectics with mandelic acid and saccharin for enhanced solubility10.1080/03639045.2020.1775633 ↗
31. A comprehensive analysis of meloxicam particles produced by nanosecond laser ablation as a wet milling technique10.1038/s41598-022-16728-9 ↗
32. Identification of a new cocrystal of citric acid and paracetamol of pharmaceutical relevance10.1039/C0CE00461H ↗
33. (2024, February 10). Pubchem Database, Available online: https://pubchem.ncbi.nlm.nih.gov/.
34. A comparative approach of MIR, NIR and Raman based chemometric strategies for quantification of Form I of Meloxicam in commercial bulk drug10.1016/j.microc.2022.107575 ↗
35. Physical characterization of meloxicam-β-cyclodextrin inclusion complex pellets prepared by a fluid-bed coating method10.1016/j.partic.2008.11.004 ↗
36. Laser Raman and infrared spectra of tartaric acid crystals10.1002/jrs.1250200206 ↗
37. Preparation and physicochemical characterization of meloxicam orally fast disintegration tablet using its solid dispersion